CTI BioPharma Corp. (CTIC)

0.79
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 0.79
Open 0.79
Day Low/High 0.79 / 0.82
52 Wk Low/High 0.60 / 1.95
Volume 66.81K
Avg Volume 128.70K
Exchange NASDAQ
Shares Outstanding 57.98M
Market Cap 47.50M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Stock Search: Citigroup, Cell Therapeutics

Stock Search: Citigroup, Cell Therapeutics

Citigroup retains the top spot on TheStreet's Stock Search list today. New entries to the list include Hewlett-Packard, Windstream and China Unicom Hong Kong.

Stock Search: Citigroup, Bank of America

Stock Search: Citigroup, Bank of America

Citigroup continues its reign in the top spot of TheStreet's Stock Search list today. New entries to the list include BB&T, Home Depot, Urban Outfitters, Cell Therapeutics and VMware.

Biotech Calendar: Key Dates and Events

Biotech Calendar: Key Dates and Events

A quick and dirty guide to important biotech events for the busy month of September.

Insiders Sell $6M Worth of Valmont

Insiders Sell $6M Worth of Valmont

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Spectrum Takes Loss Without One-time Payment

Spectrum Takes Loss Without One-time Payment

Spectrum Pharma reports loss and greater expenses; year-ago quarter included $20.7M payment

Biotech Stock Mailbag: Onyx, Savient

This week, readers weigh in on Onyx Pharma's fund-raising, Savient's gout treatment and Spectrum's Fusilev.

Biotech Calendar: Key FDA Action Dates

Biotech Calendar: Key FDA Action Dates

A quick and dirty guide to upcoming FDA approval dates for biotech drugs.

Spectrum a Takeover Target for Bayer? Color Me Skeptical

Those who believe Bayer would want to buy Spectrum for the rights to Zevalin need a strong dose of reality.

Biotech Stock Mailbag: Discovery Labs

Readers sound off on Discovery Labs, Micromet and BioDelivery.

Biotech Stock Mailbag: Cell Therapeutics

Readers write in about Cell Therapeutics' fund-raising, Onyx's buyout chances, Hemispherx's latest activities, and Curis' venture with Roche.

Biotech Stock Mailbag: Immunomedics

Biotech Stock Mailbag: Immunomedics

Readers seek insight on Immunomedics, Discovery Labs and AMAG Pharmaceuticals.

Cell Therapeutics Has to Sprint to Reach Target

Cell Therapeutics Has to Sprint to Reach Target

Cell Therapeutics will have to hustle to reach the break-even point it recently predicted for its fourth quarter.

Biotech Stock Mailbag: Spectrum

Biotech Stock Mailbag: Spectrum

Readers weigh in on Spectrum Pharma, Cell Therapeutics and Geron, and force us to explain -- again -- TheStreet's rules on stock ownership.

Stock Search: Bank of America, General Electric

Stock Search: Bank of America, General Electric

For the fourth day in a row, Bank of America remains atop TheStreet.com's stock-search list. New entries to the list include Cell Therapeutics, Hemispherx Biopharma, Vanda Pharmaceuticals and China Unicom Hong Kong.

Biotech Stock Mailbag: Gleaming the Cubist

Biotech Stock Mailbag: Gleaming the Cubist

Readers seek guidance on Cubist Pharmaceuticals and Arena's new cash haul, and wax poetic about Cell Therapeutics.

Four Must-See Charts: Biotech Stocks

Four Must-See Charts: Biotech Stocks

These biotech stocks could be setting up to make big moves.

Cell Therapeutics Still Has Heavy Debt Load

Holders of more than half of Cell Therapeutics' debt chose not to accept the company's below-par bid for their notes.

Cell Therapeutics Completes Note Exchange

Cell Therapeutics says exchange offer reduced debt by $54.8M

Cell Therapeutics: Deadline Nears for Debt Tender Offer

Cell Therapeutics is expected to disclose soon whether debtholders have accepted a tender offer to exchange cash and company stock for their notes.

Stock Search: BofA, Research in Motion

Bank of America claims the top spot on TheStreet.com's stock-search list today. New entries to the list include TriQuint Semiconductor, Huntington Bancshares Inc, Palm and Dolby Laboratories.

Cell Therapeutics May Be Added To A Russell Index

Cell Therapeutics shares surge after biotech firm says it may be listed on Russell 3000 Index

Stock Search: Bank of American, Citigroup

Bank of America and Citigroup are holding the top spots on TheStreet.com's stock-search list today. New entries to the list include Cell Therapeutics, ARYx Therapeutics, Hemispherx Biopharma and Boeing.

Biotech Stock Mailbag: Good Stocks Exist

Find out what stocks escape our biotech expert's wrath.

Another Strong Week for Stocks

Another Strong Week for Stocks

Frank Curzio breaks down the market with guest Andrew Horowitz.

Stock Search: Bank of America, Citigroup

Bank of America claimed the top spot on TheStreet.com's stock-search list today. Newcomers to the list are Hemispherx Biopharma, Boeing, Cell Therapeutics, Joy Global and BE Aerospace.

Biotech Stock Mailbag: HEB's Artful Dodging

Biotech Stock Mailbag: HEB's Artful Dodging

Readers chime in on Hemispherx, Genxyme, ASCO, Cell Therapeutics and Cardiome.

Top Takes From RealMoney

Here's what some of our market pros are saying and playing.

Cell Therapeutics Seeks Liquidity for Debt Holders

Cell Therapeutics Seeks Liquidity for Debt Holders

Cell Therapuetics is working overtime to make its stock more appealing to debt holders.

Cell Therapeutics Downplays Drug's Heart Risks

Cell Therapeutics Downplays Drug's Heart Risks

A brilliantly crafted press release sends Cell Therapeutics rocketing despite data showing heart toxicity in pixantrone.

Biotech Stock Mailbag: Gilead Still Got It?

Biotech Stock Mailbag: Gilead Still Got It?

Readers ask what the prospects are for Gilead, what to make of OncoGenex's rally, and why one cancer drug may have more upside than another.

TheStreet Quant Rating: D (Sell)